EFDID: 513869EFD: View Filing

Issuer: Perspective Therapeutics, Inc. (0000728387) - D

Accession: 0001437749-24-008296 (XMLRaw Data) (EDGAREDGAR Files) (Form DForm D)

EDGAR: Issuer Information
  • CIK:
    0000728387
  • Entity Name:
    Perspective Therapeutics, Inc.
  • Entity Type:
    Corporation
  • Jurisdiction:
    DELAWARE
  • Year of Inc:
    Over 5 years ago
  • Address:
    2401 Elliott Avenue
    Suite 320
    Seattle, WA 98121
  • Persons:
    Related Persons 8
    Johan (Thijs) Spoor
    Executive Officer, Director
    Lori Woods
    Director
    Frank Morich
    Director
    Heidi Henson
    Director
    Robert Williamson III
    Director
    Jonathan Hunt
    Executive Officer
    Markus Puhlmann
    Executive Officer
    Mark Austin
    Executive Officer
EDGAR: Offering Information
  • Accession Date:
    03/18/2024
  • First Sale Date:
    03/04/2024
  • Offering Amount:
    $87,409,482
  • Amount Sold:
    $87,409,482
  • Exemptions:
    Rule 506
  • Security Type(s):
    Equity
  • Sales Clarification:
    Based on 92,009,981 shares of common stock at $0.95 per share.
EFD: Current State Notices
View Notices

Notices found in EFD

Filed:CA, NY
EDGAR: Sales Compensation Recipient Information
RecipientCRDBroker DealerBD CRDStates
B. Riley Securities, Inc. 25027 B. Riley Securities, Inc. 25027 CA
Oppenheimer & Co. Inc. 249 Oppenheimer & Co. Inc. 249 CA, NY
LifeSci Capital, LLC 168404 LifeSci Capital, LLC 168404 CA, CT, MA, NY
JonesTrading Institutional Services LLC 6888 JonesTrading Institutional Services LLC 6888 NY
EDGAR: Signatures
IssuerSignatureSigner NameTitleSignatureDate
Perspective Therapeutics, Inc./s/ Johan (Thijs) SpoorJohan (Thijs) SpoorChief Executive Officer2024-03-18